Conexeu Sciences closed at $2.40 on Nov 2, down 5.51%, within 0.0% of its lowest close since Sep 11. Volume of 340.2K shares was 0.84× its 20-day average (close to normal).
Split-adjusted performance: -22.6% over one month.
Short interest was 297.2K shares at the Oct 15 settlement, up 41.2% from the prior report (1.8% of float, 1.0 days to cover).
No reported quarters with price history yet.
Percentile among 22 companies (100 = best)
Industry medians: 6-month return −3.4%, revenue growth +10.5%, net margin −2.8%, P/E 27.4×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| CNXUConexeu Sciences | $2.40 | −5.51% | — | — | — | — | $74.0M | |
| NTRBNutriband | $6.41 | +1.75% | +73.2% | −29.7% | −201.3% | — | $77.9M | Compare |
| SPAISafe Pro Group | $3.11 | −2.97% | −31.0% | +1336.2% | −237.9% | — | $63.2M | Compare |
| LAKELakeland Industries | $8.95 | +1.82% | −5.6% | −4.5% | −9.8% | — | $88.9M | Compare |
| APTAlpha Pro Tech | $5.52 | +2.22% | +20.0% | +12.0% | 9.8% | 13.4 | $56.3M | Compare |
| COCHEnvoy Medical | $6.65 | +0.30% | −4.3% | −34.6% | −14258.8% | — | $51.5M | Compare |
| MYOMyomo | $1.20 | −3.23% | +39.1% | +21.3% | −34.4% | — | $47.5M | Compare |
| INGNInogen | $6.87 | +0.15% | −1.4% | +3.0% | −4.0% | — | $182.3M | Compare |
| MLSSMilestone Scientific | $0.3225 | +5.88% | −9.1% | +22.3% | −37.3% | — | $29.2M | Compare |
No recent articles focused on Conexeu Sciences. 2 articles mention it in passing.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
